CUEDC2的N端结构域溶液结构初步探索

目的:为了更好地研究CUEDC2(CUE domain containing 2)的生物学功能,对其N端含133个氨基酸残基的结构域的三维结构进行初步探索。方法:用亲和纯化方法纯化GST-CUEDC2(1-133 aa)和His-CUEDC2(1-133aa),采用圆二色谱和核磁共振方法初步研究其结构。结果:圆二色谱实验表明CUEDC2(1-133 aa)cut比CUEDC2(1-133 aa)uncut的螺旋结构更多,折叠更好;核磁共振实验表明CUEDC2(1-133 aa)cut的1H-15N HSQC谱交叉峰更多,峰强度更均匀。结论:CUEDC2(1-133 aa)cut为最适合用核磁共振方法进行结构计算的片段。     

UHRF2结构域突变体的原核表达与纯化

目的构建UHRF2各个以结构域为基础的突变体原核表达载体,在大肠埃希菌中表达并对融合蛋白进行纯化和鉴定。方法以pCMV-3xFlag—UHRF2为模板,PCR扩增UHRF2的各个结构域基因片段,各PCR产物经酶切后连接到pGEX-4T-1载体上;将重组载体转化大肠埃希菌（BL21菌株）,IPTG诱导表达各GST融合蛋白,超声波破碎细菌,离心收获蛋白并经谷胱甘肽琼脂糖凝胶4B（glutathione sepharose 4B）亲合纯化;纯化的蛋白经SDS-PAGE电泳后用考马斯亮蓝染色或免疫印记实验鉴定各蛋白表达情况。结果成功构建了UHRF2结构域突变体的原核表达载体,各突变体蛋白表达正确。结论UHRF2各结构域突变体的成功构建便于用GST pull—down实验研究UHRF2参与与其它蛋白相互作用的结构域,为了解UHRF2功能打下了基础。     

酪氨酸激酶EphB2受体N端球状结构域的表达及纯化

根据酪氨酸激酶ＥｐｈＢ２受体的碱基序列,用ＰＣＲ方法扩增其结合配体的关键结构域Ｎ端球状区,定向克隆到融合表达质粒载体ｒＲＳＥＴ Ａ中,转化大肠杆菌ＪＭ１０９（ＤＥ３）。阳性克隆经ＩＰＴＧ诱导,由Ｔ７启动子调控表达了氨基端带６个连续组氨酸残基的融合蛋白。电泳分析表明,表达的融合蛋白主要以包含体的形式存在,约占细菌总蛋白的１４％。Ｗｅｓｔｅｒｎ印迹确证,利用Ｎｉ－ＮＴＡ金属螯合亲和色谱法在变性条件下对     

人体鼠双微体2 C端结构域ZF&RING 重组蛋白的表达、纯化及单体结构研究

目的:通过在大肠杆菌SUMO系统中对鼠双微体2(MDM2)C端结构域ZFRING(aa.300-491)进行构建并进行表达,酶切和纯化,从而得到MDM2蛋白C端结构域的单体结构,为其后续的晶体研究及MDM2非p53依赖途径的研究提供途径。方法:利用大肠杆菌SUMO表达系统对zfring基因进行重组构建。构建成功的表达载体经诱导表达优化后,通过Ni-NTA进行亲和层析纯化,并利用SDS-PAGE及Western blot鉴定分析。纯化后的融合蛋白经ULP1酶切得到目的蛋白ZFRING,并通过Hi Trap Q FF离子交换层析检验和去除杂质DNA。最后通过分子筛检验其蛋白结构。结果:构建了SUMO-ZFRING重组载体。重组载体在大肠杆菌高效可溶性表达,纯化并酶切后的目的蛋白ZFRING以单体形式存在。结论:通过原核表达、纯化、酶切及层析发鉴定,成功获得高稳定、高纯度且为单体结构的MDM2 C端结构域ZFRING蛋白,为后续关于MDM2,尤其是其非p53依赖途径的结构学和功能学提供了思路和途径。     

His-tag的人胞浆磷脂酶A_2的C2结构域的表达、纯化及性质

带有His tag的人胞浆磷脂酶A2 的C2结构域高效表达 ,用内源荧光的变化测定了其稳定性和其与钙离子结合的结合常数 .结果表明 ,带有His tag的C2结构域仍可有效用于研究其折叠及其与钙离子的协同性结合 ,温度从 2 2℃升高到 35℃时 ,C2结构域和钙离子结合的协同性程度显著增强 .     

结构生物学研究中的eIF-5A的表达与纯化

真核细胞翻译官始因子eIF-5A（eukaryotic initiation factor 5A）是迄今发现的惟一含有特殊氨基酸hypusine残基的蛋白质,其具体生物学功能仍不明确。为了推进对其功能的研究,拟从结构生物学入手,对其结构进行核磁共振（NMR）结构解析。利用GST融合蛋白原核表达系统,将eIF-5A进行原核表达,经过优化表达与纯化条件,得到了高产率与高纯度的可溶性eIF-5A用以进行NMR测试：经过!1H-^15N HSQC NMR实验,发现其适合应用NMR方法进行结构解析,从而为溶液中eIF-5A三维构象的研究奠定了基础.     

人EGF受体L2结构域在大肠杆菌中表达、包涵体柱上复性及纯化

以PCR方法从克隆的EGFR胞外区cDNA中扩增编码EGFR-L2结构域的DNA片段,在其3′端加入编码His6标签的序列,与pET-3c连接构建EGFR-L2原核表达载体。该蛋白在大肠杆菌BL21(DE3)中获得高效表达,免疫印迹分析表明表达产物全部以包涵体形式存在,分步透析法和稀释法都不能获得可溶性复性产物,而Ni²⁺-NTA柱上复性法不仅能够获得可溶性的EGFR-L2蛋白,而且产物同时得到高度纯化,纯度>95％,复性的EGFR-L2与其配基EGF具有特异性的结合活性,但亲和力较低。这表明His6标签不但便于纯化目标蛋白,而且可利用Ni²⁺-NTA柱进行柱上复性,适用于不易通过常规方法复性的重组蛋白的制备。     

盘状结构域受体2胞外区的可溶性表达、纯化和功能鉴定

盘状结构域受体2（discoidin domain receptor 2,DDR2）是一种与肿瘤细胞转移相关的蛋白酷氨酸激酶,其配体为纤维性胶原,胶原对DDR2的活化上调细胞中基质金属蛋白酶1（MMP－1）的表达。为研究DDR2在类风温性关节炎(rteumatoid arthritis,RA）软骨破坏和肿瘤转移中的作用,尝试了在大肠杆菌中表达一段DDR2胞外区（命名DB）,并进行了可溶性部分的纯化和功能鉴定,以备将来用作DDR2的特异性阻断剂。获得了一株表达GST－DB融合蛋白的大肠杆菌克隆;其表达的蛋白质中可溶性部分约占全部融合蛋白的13％;经GST融合蛋白特异性亲和珠纯化后,获得了纯度约86.1%的可溶性GST－DB融合蛋白;竞争结合抑制实验显示,GST－DB具有阻断Ⅱ型胶原和细胞表面天然DDR2受体结合的功能;细胞实验表明,GST－DB有抑制Ⅱ型胶原刺激下的类风湿性关节炎滑膜细胞和NIH3T3细胞分泌MMP－1的作用。以上结果提示,表达的融保蛋白GST－DB具有抑制天然DDR2功能的作用;DDR2在滑膜细胞和NIH3T3细胞中介导Ⅱ型胶原刺激下的MMP－1的分泌。     

人ppGalNAc-T2的原核表达、纯化及其蓖麻蛋白样结构域的结构预测

多肽∶N乙酰氨基半乳糖转移酶(ppGalNAcT)是催化O糖基化的起始酶,在O聚糖的形成中起着关键的作用.为更好地研究该家族酶的结构与功能,采用PCR技术从pDONR201T2得到ppGalNAcT2全长编码序列,亚克隆至原核表达载体pGEX4T1,转化大肠杆菌BL21,获得相应表达产物,用谷胱甘肽S转移酶(GST)亲和层析柱进行纯化,并进行了Western印迹检测和初步的酶活测定.为进一步研究其功能还在结构研究上利用网络结构模拟SWISSMODEL服务器对ppGalNAcT2的蓖麻蛋白样结构域进行结构模拟.成功构建了原核表达载体pGEX4T1T2,获得有效表达和纯化,并初步鉴定了其活性,同时预测了其可能的三维结构和活性位点.     

OSBP的PH结构域的融合表达纯化及其二级结构的初步分析

氧类固醇结合蛋白（OSBP）是胆固醇类代谢过程的调节物。为了进一步研究OSBP的功能以及结构与功能之间的关系,将OSBP PH－pRSET-A的质粒转化入E.coli JM109（DE3）,并在无机培养基中获得高效可溶表达。表达的蛋白质经Ni^2 -NTA偶联的琼脂糖珠纯化,通过圆二色性分析纯化的蛋白质的二级结构,结果为：α螺旋占7.2%,β折叠占71.1%,无规则卷曲占21.7%。     

应用酵母双杂交筛选与CUEDC2相互作用的蛋白质

目的：应用酵母双杂交技术,筛选与包含CUE结构域的人CUEDC2发生相互作用的蛋白质。方法：应用酵母双杂交系统,以CUEDC2为诱饵筛选人乳腺cDNA文库,寻找能与之相互作用的蛋白质,并运用营养缺陷型培养和X-alpha-Gal等实验提供的信息,筛除假阳性克隆。结果：以CUEDC2为诱饵最终筛出了2个阳性克隆,经测序及生物信息学分析,这2个克隆同为GADD34。结论：CUEDC2可以和GADD34发生相互作用,它们的相互作用有可能与CUEDC2的功能调控相关。     

CUEDC2 interacts with heat shock protein 70 and negatively regulates its chaperone activity

Recently studies have revealed that CUEDC2, a CUE domain-containing protein, plays critical roles in many biological processes, such as cell cycle, inflammation and tumorigenesis. In this study, to further explore the function of CUEDC2, we performed affinity purification combined with mass spectrometry analysis to identify its interaction proteins, which led to the identification of heat shock protein 70 (HSP70). We confirmed the interaction between CUEDC2 and HSP70 in vivo by co-immunoprecipitation assays. Mapping experiments revealed that CUE domain was required for their binding, while the PBD and CT domains of HSP70, mediated the interaction with CUEDC2. The intracellular Luciferase refolding assay indicated that CUEDC2 could inhibit the chaperone activity of HSP70. Together, our results identify HSP70 as a novel CUEDC2 interaction protein and suggest that CUEDC2 might play important roles in regulating HSP70 mediated stress responses.     

Purification and characterization of anti-tubercular and anticancer protein from Staphylococcus hominis strain MANF2: In silico structural and functional insight of peptide

The present context was investigated to purify and characterize anti-tubercular as well as anticancer protein from fermented food associated Staphylococcus hominis strain MANF2. Initially, the anti-tubercular potency of strain MANF2 was assessed against Mycobacterium tuberculosis H37Rv using luciferase reporter phase assay which revealed pronounced relative light unit (RLU) reduction of 92.5 ± 1.2%. The anticancer property of strain MANF2 was demonstrated against lung cancer (A549) and colon cancer (HT-29) cell lines using MTT assay which showed reduced viabilities. Anti-tubercular activities of the purified protein were observed to be increased significantly (P < 0.05) ranging from 34.6 ± 0.3 to 71.4 ± 0.4% of RLU reduction. Likewise, the purified protein showed significantly (P < 0.05) reduced viabilities of A549 and HT-29 cancer cells with IC₅₀ values of 46.6 and 48.9 µg/mL, respectively. The nominal mass of the purified protein was found to be 7712.3 Da as obtained from MALDI-TOF MS/MS spectrum. The protein showed the sequence homology with 1–336 amino acids of Glyceraldehyde-3-phosphate dehydrogenase from Staphylococcus sp., thus, categorizing as a new class of Glyceraldehyde-3-phosphate dehydrogenase-like protein. The amino acid sequence of the most abundant peptide (m/z = 1922.12) in the purified protein was obtained as ‘KAIGLVIPEIDGKLDGGAQRV’ and it was identified as peptide NMANF2. In silico tools predicted significant stereo-chemical, physiochemical, and functional characteristics of peptide NMANF2. In a nutshell, protein purified from strain MANF2 can certainly be used as an ideal therapeutic agent against tuberculosis and cancer (lung and colon).     

CUE domain‐containing protein 2 promotes the Warburg effect and tumorigenesis

Cancer progression depends on cellular metabolic reprogramming as both direct and indirect consequence of oncogenic lesions; however, the underlying mechanisms are still poorly understood. Here, we report that CUEDC2 (CUE domain‐containing protein 2) plays a vital role in facilitating aerobic glycolysis, or Warburg effect, in cancer cells. Mechanistically, we show that CUEDC2 upregulates the two key glycolytic proteins GLUT3 and LDHA via interacting with the glucocorticoid receptor (GR) or 14‐3‐3ζ, respectively. We further demonstrate that enhanced aerobic glycolysis is essential for the role of CUEDC2 to drive cancer progression. Moreover, using tissue microarray analysis, we show a correlation between the aberrant expression of CUEDC2, and GLUT3 and LDHA in clinical HCC samples, further demonstrating a link between CUEDC2 and the Warburg effect during cancer development. Taken together, our findings reveal a previously unappreciated function of CUEDC2 in cancer cell metabolism and tumorigenesis, illustrating how close oncogenic lesions are intertwined with metabolic alterations promoting cancer progression.     

HER-2/neu胞外配体结合区2在大肠杆菌中可溶性表达及纯化

用PCR技术扩增HER 2 neu胞外配体结合区 2 (RLD2 )cDNA ,并将扩增的基因片段克隆于硫氧还蛋白 (TrxA)原核表达载体中 ,获得TrxA RLD2融合蛋白的可溶性表达 .通过插入偶联翻译序列 ,实现TrxA与RLD2蛋白在大肠杆菌中的共表达 .表达产物经免疫印记检测可被抗HER 2 neu特异性抗体识别 .经离子交换层析和钴亲和层析纯化 ,RLD2蛋白的纯度达 90 % .用质谱法分析RLD2蛋白的分子量 ,与预期值相符 .结果表明 ,利用TrxA表达体系在大肠杆菌中获得了HER 2 neuRLD2蛋白高效可溶性表达     

Purification and Recombinant Expression of Major Peanut Allergen Ara h 1

Reaction to peanut, as one of the major food allergens, has become an increasingly common life-threatening disorder. Although peanut allergens have been extensively identified, Ara h 1 is still too expensive to be applied in food safety or clinical utility. In this study, the purification, expression, and immunological analyses of Ara h 1 are investigated. It was shown that a high purity (>95%) of Ara h 1 could be prepared by either purification or expression. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), Western blot, and mass spectroscopy were used to identify the Ara h 1, and it was found that natural Ara h 1 (nAra h 1) and expressed Ara h 1 (rAra h 1) have the same properties, including amino acid sequence. In particular, rAra h 1 reacted positively with anti-nAra h 1 serum, showing their similar immunological property. Thus, by either purification or expression, Ara h 1 could be prepared with low cost, as performed in the present work. SDS-PAGE, mag trix-assisted laser desorption/ionization time-of-flight mass spectroscopy (MALDI-TOF MS), and immunological analysis confirmed that both forms of Ara h 1 had the same properties.